WO2002032233A3 - Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin - Google Patents

Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin Download PDF

Info

Publication number
WO2002032233A3
WO2002032233A3 PCT/GB2001/004575 GB0104575W WO0232233A3 WO 2002032233 A3 WO2002032233 A3 WO 2002032233A3 GB 0104575 W GB0104575 W GB 0104575W WO 0232233 A3 WO0232233 A3 WO 0232233A3
Authority
WO
WIPO (PCT)
Prior art keywords
diseases
infections
poultry
pigs
aivlosin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2001/004575
Other languages
French (fr)
Other versions
WO2002032233A2 (en
Inventor
Michael John Sanders
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eco Animal Health Ltd
Original Assignee
Eco Animal Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9901546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2002032233(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to BR122013012292A priority Critical patent/BR122013012292B1/en
Priority to BRPI0114703A priority patent/BRPI0114703B1/en
Priority to DE60125212T priority patent/DE60125212T2/en
Priority to JP2002535483A priority patent/JP4335524B2/en
Priority to BR122013012293A priority patent/BR122013012293B1/en
Priority to EP01976452A priority patent/EP1326599B1/en
Priority to BR122013012291A priority patent/BR122013012291B1/en
Priority to CA002425319A priority patent/CA2425319C/en
Application filed by Eco Animal Health Ltd filed Critical Eco Animal Health Ltd
Priority to AU2001295722A priority patent/AU2001295722A1/en
Priority to KR1020037004964A priority patent/KR100866021B1/en
Priority to PL362085A priority patent/PL221310B1/en
Priority to MXPA03003309A priority patent/MXPA03003309A/en
Priority to US10/398,086 priority patent/US20040082524A1/en
Priority to DK01976452T priority patent/DK1326599T3/en
Publication of WO2002032233A2 publication Critical patent/WO2002032233A2/en
Publication of WO2002032233A3 publication Critical patent/WO2002032233A3/en
Anticipated expiration legal-status Critical
Priority to US11/479,721 priority patent/US20060247184A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Feed For Specific Animals (AREA)

Abstract

The use of aivlosin, as much or as a pharmacologically acceptable (non-toxic) derivative such as an acid addition salt, for the preparation of a veterinary medicament for the treatment or prophylaxis of diseases and infections of pigs and poultry. In particular the diseases and infections treatable are necrotic enteritis in poultry and Lawsonia infections, Mycoplasma diseases and swine dysentery in pigs.
PCT/GB2001/004575 2000-10-18 2001-10-15 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin Ceased WO2002032233A2 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
DK01976452T DK1326599T3 (en) 2000-10-18 2001-10-15 Use of aivlosin for the treatment or prevention of Lawsonia infections in pigs
BRPI0114703A BRPI0114703B1 (en) 2000-10-18 2001-10-15 use of 3-o-acetyl-4'-isovaleryl tylosin or a pharmacologically acceptable acid addition salt, pig feed, stable coated composition for addition to an animal feed and veterinary medicinal product
DE60125212T DE60125212T2 (en) 2000-10-18 2001-10-15 Use of Aivlosin for the treatment and prevention of Lawsonia infections in pigs.
JP2002535483A JP4335524B2 (en) 2000-10-18 2001-10-15 Treatment and prevention of diseases and infections in pigs and poultry
BR122013012293A BR122013012293B1 (en) 2000-10-18 2001-10-15 use of 3-o-acetyl-4 '-o-isovaleryl tylosin or a pharmaceutically acceptable acid addition salt or other derivative thereof, poultry feed, stable coated composition for addition to an animal feed and veterinary medicinal product
EP01976452A EP1326599B1 (en) 2000-10-18 2001-10-15 Use of aivlosin for treating or preventing Lawsonia infections in pigs.
BR122013012291A BR122013012291B1 (en) 2000-10-18 2001-10-15 use of 3-o-acetyl-4 '-o-isovaleryl tylosin or a pharmaceutically acceptable acid addition salt or other derivative thereof, pig feed, stable coated composition for addition to an animal feed and veterinary medicinal product
CA002425319A CA2425319C (en) 2000-10-18 2001-10-15 Treatment and prophylaxis of diseases and infections of pigs and poultry
AU2001295722A AU2001295722A1 (en) 2000-10-18 2001-10-15 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin
BR122013012292A BR122013012292B1 (en) 2000-10-18 2001-10-15 use of 3-o-acetyl-4 '-o-isovaleryl tylosin or a pharmaceutically acceptable acid addition salt or other derivative thereof, poultry feed and swine, stable coated composition for addition to an animal feed and medicament vet
MXPA03003309A MXPA03003309A (en) 2000-10-18 2001-10-15 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin.
PL362085A PL221310B1 (en) 2000-10-18 2001-10-15 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin
KR1020037004964A KR100866021B1 (en) 2000-10-18 2001-10-15 Compositions for the treatment and prevention of diseases and infections in pigs and poultry
US10/398,086 US20040082524A1 (en) 2000-10-18 2001-10-15 Treatment and prophylaxis of diseases and infections of pigs and poultry
US11/479,721 US20060247184A1 (en) 2000-10-18 2006-06-30 Treatment and prophylaxis of diseases and infections pigs and poultry

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0025556.2A GB0025556D0 (en) 2000-10-18 2000-10-18 Treatment and prophylaxis of disease and infections of pigs and poultry
GB0025556.2 2000-10-18

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/479,721 Continuation US20060247184A1 (en) 2000-10-18 2006-06-30 Treatment and prophylaxis of diseases and infections pigs and poultry

Publications (2)

Publication Number Publication Date
WO2002032233A2 WO2002032233A2 (en) 2002-04-25
WO2002032233A3 true WO2002032233A3 (en) 2002-08-01

Family

ID=9901546

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/004575 Ceased WO2002032233A2 (en) 2000-10-18 2001-10-15 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin

Country Status (20)

Country Link
US (2) US20040082524A1 (en)
EP (1) EP1326599B1 (en)
JP (2) JP4335524B2 (en)
KR (2) KR100866021B1 (en)
CN (6) CN100471501C (en)
AR (2) AR031002A1 (en)
AT (1) ATE347888T1 (en)
AU (1) AU2001295722A1 (en)
BR (4) BR122013012291B1 (en)
CA (1) CA2425319C (en)
CY (1) CY1107480T1 (en)
DE (1) DE60125212T2 (en)
DK (1) DK1326599T3 (en)
ES (1) ES2278788T3 (en)
GB (1) GB0025556D0 (en)
MX (1) MXPA03003309A (en)
PL (1) PL221310B1 (en)
PT (1) PT1326599E (en)
RU (2) RU2310446C2 (en)
WO (1) WO2002032233A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0315629D0 (en) * 2003-07-03 2003-08-13 Eco Animal Health Ltd New uses for antibiotic
PT2043661E (en) * 2006-07-13 2014-12-22 Eco Animal Health Ltd Use of tylvalosin as antiviral agent
GB0613952D0 (en) * 2006-07-13 2006-08-23 Eco Animal Health Ltd Antiviral agent
RU2487709C2 (en) * 2011-06-01 2013-07-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Белгородская государственная сельскохозяйственная академия имени В.Я. Горина" (ФГБОУ БелГСХА им. В.Я. Горина) Compositional preparation for treating pneumonia in piglets
WO2014175757A1 (en) * 2013-04-22 2014-10-30 Общество с ограниченной ответственностью "Нанобиотех" Antiseptic veterinary formulation and methods for use thereof
CN104127429A (en) * 2014-07-28 2014-11-05 邳州正康生物技术有限公司 Drinking water agent for preventing and treating livestock and poultry respiratory tract diseases and preparation method thereof
CN104256168B (en) * 2014-09-28 2016-05-11 山东新希望六和集团有限公司 One boar functional feed and preparation method thereof
CN106361707B (en) * 2016-09-30 2019-02-26 广东温氏大华农生物科技有限公司 Ten thousand rhzomorph granular preparations of a kind of tartaric acid Thailand and preparation method thereof
CN107625779A (en) * 2017-10-19 2018-01-26 洛阳瑞华动物保健品有限公司 A kind of pharmaceutical preparation, kit for being used to suppress PRRS virus duplication
CN118021765B (en) * 2024-04-15 2024-08-06 中国农业科学院农业环境与可持续发展研究所 Taqniamycin tartrate nano-preparation and preparation method thereof
CN118845646B (en) * 2024-09-24 2024-12-13 中国农业大学 Taqniamycin tartrate nano suspension and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0121328A2 (en) * 1983-03-03 1984-10-10 Eli Lilly And Company Macrolide derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52139088A (en) * 1976-05-15 1977-11-19 Sanraku Inc Antibiotics tyrocin derivatives and their preparation
US4201843A (en) * 1975-08-01 1980-05-06 Sanraku Ocean Co., Ltd. Process for manufacturing tylosin derivatives
US4092473A (en) * 1975-08-01 1978-05-30 Sanraku Ocean Co., Ltd. Tylosin derivatives and their manufacturing process
US4559301A (en) * 1983-03-03 1985-12-17 Eli Lilly And Company Process for preparing macrocin derivatives
US4582822A (en) * 1984-10-09 1986-04-15 Eli Lilly And Company Antibiotic A80190, pharmaceutical compositions containing same and method of use
DE3725946A1 (en) * 1987-08-05 1989-02-16 Boehringer Ingelheim Vetmed STABILIZED FEED ADDITIVE AND METHOD FOR THE PRODUCTION THEREOF
SE9801742L (en) * 1998-05-18 1999-11-19 Akzo Nobel Nv Use of natural substances containing thymol in the preparation of animal feed
US6326364B1 (en) * 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0121328A2 (en) * 1983-03-03 1984-10-10 Eli Lilly And Company Macrolide derivatives

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; CHO, SEUNG-KUN ET AL: "Studies on efficacy and establishment of withdrawal time of acetyl isovaleryl tylosin tartrate and chlortetracycline combination therapy in swine, II. Field efficacy trials of acetyl isovaleryl tylosin tartrate an chlortetracycline combination", XP002189928, retrieved from STN Database accession no. 130:177172 HCA *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; LEE, MUN-HAN ET AL: "Studies on efficacy and establishment of withdrawal time of acetyl isovaleryl tylosin tartrate and chlortetracycline combination for bacterial pneumonia therapy in swine: I. Antimicrobial activity of acetyl isovaleryl tylosin tartrate and chlortetracycline combination in vitro", XP002189926, retrieved from STN Database accession no. 130:217665 HCA *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; LEE, MUN-HAN ET AL: "Studies on efficacy and establishment of withdrawal time of acetyl isovaleryl tylosin tartrate and chlortetracycline combination therapy in swine. III. Establishment of withdrawal time of acetyl isovaleryl tylosin tartrate and chlortetracycline combination", XP002189927, retrieved from STN Database accession no. 130:191458 HCA *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; OKUYAMA, DAISAKU: "3-Acetyl-4''-isovaleryltylosin, a new animal drug", XP002190573, retrieved from STN Database accession no. 119:194935 HCA *
JACKS, T.M., ET AL: "3-Acetyl-4''-isovalereyl tylosin for prevention of swine dysentry", AMERICAN JOURNAL OF VETERINARY RESEARCH, vol. 47, no. 11, 1986, pages 2325 - 2328, XP001053272 *
KACHIKU KOKINZAI KENKYUKAIHO (1991), 12, 44-57 *
SKELLY, B.J., ET AL: "Prophylactic efficacy of 3-acetyl-4''-isovaleryl tylosin in a mycoplasma gallisepticum-induced airsacculitis infection", AVIAN DISEASES, vol. 30, no. 3, 1986, pages 505 - 509, XP001053258 *
SOUL TAEHAKKYO SUUIDAE NONMUNJIP (1997), 22(1), 57-62 *
SOUL TAEHAKKYO SUUIDAE NONMUNJIP (1998), 23(1), 19-24 *
SOUL TAEHAKKYO SUUIDAE NONMUNJIP (1998), 23(1), 25-34 *

Also Published As

Publication number Publication date
CN1469742A (en) 2004-01-21
US20060247184A1 (en) 2006-11-02
CN1803140A (en) 2006-07-19
JP2008297316A (en) 2008-12-11
KR100919725B1 (en) 2009-09-29
BRPI0114703B1 (en) 2016-07-05
GB0025556D0 (en) 2000-12-06
CY1107480T1 (en) 2013-03-13
EP1326599A2 (en) 2003-07-16
DE60125212T2 (en) 2007-11-15
JP5001234B2 (en) 2012-08-15
CN100471501C (en) 2009-03-25
JP4335524B2 (en) 2009-09-30
BR122013012293B1 (en) 2016-06-21
WO2002032233A2 (en) 2002-04-25
CN1803142A (en) 2006-07-19
CA2425319C (en) 2010-01-05
DE60125212D1 (en) 2007-01-25
PL221310B1 (en) 2016-03-31
US20040082524A1 (en) 2004-04-29
JP2004511498A (en) 2004-04-15
EP1326599B1 (en) 2006-12-13
CN1771980A (en) 2006-05-17
BR122013012292B1 (en) 2016-06-21
CN1853644A (en) 2006-11-01
RU2007105450A (en) 2008-08-20
BR122013012291B1 (en) 2016-06-21
KR100866021B1 (en) 2008-10-31
AR031002A1 (en) 2003-09-03
PT1326599E (en) 2007-03-30
PL362085A1 (en) 2004-10-18
AU2001295722A1 (en) 2002-04-29
KR20030046491A (en) 2003-06-12
KR20090005287A (en) 2009-01-13
BR0114703A (en) 2003-12-23
CN1853644B (en) 2010-12-08
RU2310446C2 (en) 2007-11-20
CN1803141A (en) 2006-07-19
DK1326599T3 (en) 2007-04-10
ATE347888T1 (en) 2007-01-15
ES2278788T3 (en) 2007-08-16
MXPA03003309A (en) 2003-06-19
AR098251A2 (en) 2016-05-18
RU2454230C2 (en) 2012-06-27
CA2425319A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
CY1107480T1 (en) USE OF AIVLOSIN FOR TREATMENT AND PREVENTION OF LAWSONIA INFECTIONS IN PIGS
MY125356A (en) Moxifloxacin/sodium chloride formulation
WO2001092288A3 (en) Cobalamin compounds useful as antibiotic agents and as imaging agents
MY146351A (en) Compositions for treating infection in cattle and swine
WO2003096989A3 (en) Anti tubercular drug: compositions and methods
BRPI0412526A (en) compound, use of a compound, pharmaceutical composition, pharmaceutical aerosol formulation, and method for treating a human or animal patient with an anti-inflammatory and / or allergic condition
BRPI0418098A (en) veterinary formulations not containing animal products
CA2363990A1 (en) Use of glycyrrhizin in the treatment of mastitis
WO2004089355A8 (en) Compositions for treating microbial and parasitic infections in cattle and other animals
EP0938899A3 (en) Agent for improving the blood circulation
WO1999062459A3 (en) Agents and methods for protection, treatment and repair of connective tissue
IL172423A0 (en) Novel formulations for opioid -based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
AU2003290015A1 (en) Mastitis treatment
CA2419471A1 (en) Use of triazinetrione sulphones for controlling coccidioses
WO2004039822A3 (en) 4’’ - modified erythromycin derivatives
WO1999012552A8 (en) 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
WO2001045685A3 (en) Formulations of adenosine a1 agonists
BR0210063A (en) Stable composition and use
EP1510214A3 (en) 8a-azalides as veterinary antimicrobial agents
WO2001045727A3 (en) Stabilized veterinary compositions comprising more than one antiviral agent
AR037543A1 (en) METHOD FOR CANCER THERAPY AND PHARMACEUTICAL COMPOSITION
WO2000041473A3 (en) Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
WO2001045714A3 (en) Formulations of adenosine a1 agonists
BRPI0414223A (en) use of gentiana lutea extracts as an antimicrobial agent
RU94025885A (en) PREPARATION FOR THE TREATMENT OF BACTERIAL ORIGIN DISEASES OF AGRICULTURAL ANIMALS

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001976452

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10398086

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 00519/DELNP/2003

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2425319

Country of ref document: CA

Ref document number: 1020037004964

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 018173683

Country of ref document: CN

Ref document number: PA/a/2003/010970

Country of ref document: MX

Ref document number: PA/a/2003/003309

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2002535483

Country of ref document: JP

ENP Entry into the national phase

Ref document number: 2003114412

Country of ref document: RU

Kind code of ref document: A

Ref country code: RU

Ref document number: RU A

WWP Wipo information: published in national office

Ref document number: 1020037004964

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2001976452

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2001976452

Country of ref document: EP